Evidence map›Paper›PMID 28494187›Full record

ArticleCancer biology & therapy2017

The screening of the functional microRNA binding site SNPs in sporadic colorectal cancer genes.

Hongjuan He, Lei Lei, Erfei Chen, Xiaona Xu, Lili Wang, Junqiang Pan, Fangfang Yang, Min Wang, Jing Dong, Jin Yang

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Hongjuan Hea College of Life Science, Institute of Preventive Genomic Medicine, Northwest University , Xi'an , Shaanxi , China.
Lei Leia College of Life Science, Institute of Preventive Genomic Medicine, Northwest University , Xi'an , Shaanxi , China.
Erfei Chena College of Life Science, Institute of Preventive Genomic Medicine, Northwest University , Xi'an , Shaanxi , China.
Xiaona Xua College of Life Science, Institute of Preventive Genomic Medicine, Northwest University , Xi'an , Shaanxi , China.
Lili Wanga College of Life Science, Institute of Preventive Genomic Medicine, Northwest University , Xi'an , Shaanxi , China.
Junqiang Pana College of Life Science, Institute of Preventive Genomic Medicine, Northwest University , Xi'an , Shaanxi , China.
Fangfang Yanga College of Life Science, Institute of Preventive Genomic Medicine, Northwest University , Xi'an , Shaanxi , China.
Min Wanga College of Life Science, Institute of Preventive Genomic Medicine, Northwest University , Xi'an , Shaanxi , China.
Jing Donga College of Life Science, Institute of Preventive Genomic Medicine, Northwest University , Xi'an , Shaanxi , China.
Jin Yanga College of Life Science, Institute of Preventive Genomic Medicine, Northwest University , Xi'an , Shaanxi , China.
Northwest University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporadic colorectal cancer (sCRC) is one of the most commonly diagnosed cancers worldwide, but few genetic markers have been identified and used for its early detection. MicroRNAs are diverse cellular regulators in cancer pathogenesis that bind to the 3'-untranslated region (3'-UTR) of their target mRNAs, and variants within the miRNA target sites on sCRC-related genes may influence its pathogenesis. To investigate this possibility, we used a bioinformatical method to screen SNPs for putative changes in miRNA recognition sites within the 3'-UTR of sCRC-related genes. The rs11466537 single nucleotide polymorphism was predicted to modify the regulation of hsa-miR-1193 on the Transforming Growth Factor β Receptor II (TGFBR2) gene. Additionally, luciferase reporter assays indicated that hsa-miR-1193 bound the T allele more strongly than the A allele of rs11466537 (with A being the less frequent variant), and real time-polymerase chain reaction and western blot analysis showed that TGFBR2 is significantly repressed by hsa-miR-1193. Furthermore, overexpression of hsa-miR-1193 promoted HT-29 cell proliferation, while the loss of hsa-miR-1193 inhibited the process. Finally, the rs11466537 genotyping result revealed that the frequency of A allele carriers was 1.5% in the control blood samples, but 0 in the sCRC patients' normal colon tissue samples. Our results demonstrated that hsa-miR-1193 may be involved in sCRC tumourigenesis at least in part by suppression of TGFBR2, and the A allele of rs11466537 disturbed the regulation of hsa-miR-1193 on TGFBR2.

Indexed as

Polymorphism, Single NucleotideBase SequenceBinding SitesCase-Control StudiesCell ProliferationColorectal NeoplasmsGene ExpressionGene Expression Regulation, NeoplasticGenetic Association StudiesGenetic Predisposition to DiseaseHCT116 CellsHT29 CellsHumansMicroRNAsProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaMicroRNAsMIRN1193 microRNA, humanProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type II3′-untranslated regionmicroRNAprotective factorseed regionsingle nucleotide polymorphismssporadic colorectal cancerTGFBR2

Identifiers

PMID28494187
PMCPMC5536933
OpenAlexW2613576462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.